Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Richens

Showing results (31-40 of 270) with videos related to

Pageof 27
Sort By:
Epilepsia|January 1, 1994
Safety of lamotrigineA Richens
The Practitioner|November 1, 1975
Sensible prescribing. XI.--Juvenile and adult epilepsyA Richens
CNS Drugs|January 23, 2013
Impact of generic substitution of anticonvulsants on the treatment of epilepsyA Richens
British Journal of Clinical Practice. Supplement|March 1, 1988
The risks and benefits of current and new anti-epileptic drugsA Richens
British Journal of Clinical Pharmacology|November 1, 1978
Plasma protein binding interaction between valproic acid and palmitic acid in vitro [proceedings]A Monks, A Richens
British Journal of Clinical Pharmacology|February 1, 1979
Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugsE Perucca, A Richens
British Journal of Clinical Pharmacology|April 1, 1982
Valproic acid and diazepam interaction in vivoS Dhillon, A Richens
Ciba Foundation Symposium|January 1, 1979
Interpretation of drug levels: relevance of plasma protein bindingE Perucca, A Richens
British Medical Journal|November 1, 1975
Controlled trial of sodium valproate in severe epilepsyA Richens, S Ahmad
Drug Safety|May 1, 1994
A risk-benefit assessment of vigabatrin in the treatment of neurological disordersJ Srinivasan, A Richens
Pageof 27

Showing results (31-40 of 270) with videos related to

Sort By:
Pageof 27
Epilepsia|January 1, 1994
Safety of lamotrigineA Richens
The Practitioner|November 1, 1975
Sensible prescribing. XI.--Juvenile and adult epilepsyA Richens
CNS Drugs|January 23, 2013
Impact of generic substitution of anticonvulsants on the treatment of epilepsyA Richens
British Journal of Clinical Practice. Supplement|March 1, 1988
The risks and benefits of current and new anti-epileptic drugsA Richens
British Journal of Clinical Pharmacology|November 1, 1978
Plasma protein binding interaction between valproic acid and palmitic acid in vitro [proceedings]A Monks, A Richens
British Journal of Clinical Pharmacology|February 1, 1979
Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugsE Perucca, A Richens
British Journal of Clinical Pharmacology|April 1, 1982
Valproic acid and diazepam interaction in vivoS Dhillon, A Richens
Ciba Foundation Symposium|January 1, 1979
Interpretation of drug levels: relevance of plasma protein bindingE Perucca, A Richens
British Medical Journal|November 1, 1975
Controlled trial of sodium valproate in severe epilepsyA Richens, S Ahmad
Drug Safety|May 1, 1994
A risk-benefit assessment of vigabatrin in the treatment of neurological disordersJ Srinivasan, A Richens
Pageof 27